临床和实验性高血压 SCIESCI

期刊简介预计审稿时间：较慢,6-12周

Serving as an international forum for the exchange of state-of-the-art scientific and clinical information on all aspects of human and animal hypertension, this authoritative journal publishes full articles as well as solicited and unsolicited reviews and commentaries that extend current understanding as well as facilitate the timely and successful detection, management, control, and prevention of hypertension-related conditions.

Features special issues covering proceedings of symposia on hypertension research!

Clinical and Experimental Hypertension maintains a rapid communications format that brings readers new and important research and findings in a prompt and reliable publication schedule in areas, including:

antihypertensive agents

circulatory control

drug development and application

etiology

mechanisms of action

neurogenic mechanisms

pathophysiology

pharmacological and nonpharmacological treatment

and much more!

作为就人类和动物高血压的各个方面交流最先进的科学和临床信息的国际论坛，这本权威期刊发表全文以及征集和非征集的评论和评论，扩展当前了解并促进及时和成功地检测、管理、控制和预防高血压相关疾病。

专题报道高血压研究专题讨论会的特刊！

Clinical and Experimental Hypertension 保持着一种快速的交流形式，能够在及时可靠的出版时间表中为读者带来新的重要研究和发现，这些领域包括：

抗高血压药

循环控制

药物开发与应用

病因

作用机制

神经发生机制

病理生理学

药物治疗和非药物治疗

还有更多！

《Clinical And Experimental Hypertension》(临床和实验性高血压)编辑部通讯方式为Informa plc ("Informa") ,Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。